公开(公告)号：US20170348261A1

公开(公告)日：2017-12-07

申请号：US15539477

申请日：2015-12-24

Applicant: NIPRO CORPORATION

Inventor： Noriko NAKAJIMA ,  Takehumi OFUSA

IPC: A61K31/192 ,  A61K9/06 ,  A61K47/44 ,  A61K47/28 ,  A61K47/14 ,  A61K47/10 ,  A61K47/06 ,  A61K9/107 ,  A61K8/06 ,  A61K9/00 ,  A61K8/92 ,  A61K8/86 ,  A61K8/63 ,  A61K8/37 ,  A61K8/368 ,  A61K8/34 ,  A61K8/31 ,  A61Q19/00

CPC classification number: A61K31/192 ,  A61K8/06 ,  A61K8/31 ,  A61K8/342 ,  A61K8/345 ,  A61K8/368 ,  A61K8/37 ,  A61K8/375 ,  A61K8/63 ,  A61K8/86 ,  A61K8/92 ,  A61K8/922 ,  A61K9/0014 ,  A61K9/06 ,  A61K9/10 ,  A61K9/107 ,  A61K47/06 ,  A61K47/10 ,  A61K47/14 ,  A61K47/28 ,  A61K47/34 ,  A61K47/44 ,  A61K2800/75 ,  A61Q19/00 ,  A61Q19/007

Abstract: The present invention relates to a medical dermatological preparation for external use comprising an active drug, polyoxyethylene arachyl ether, stearyl alcohol, a liquid oily ingredient, a moisturizing ingredient and water, and provides a medical dermatological preparation for external use, which reduces occurrence or degree of a side effect such as skin irritation in the medical dermatological preparation for external use. The present invention provides particularly a medical dermatological preparation for external use, which comprises adapalene and reduces occurrence and degree of a side effect such as skin irritation.